{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:56:07Z","timestamp":1791896167353,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SIN-LIMPE Foundations.","award":["Grant Segala 2021\/2022"],"award-info":[{"award-number":["Grant Segala 2021\/2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00415-024-12802-6","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:22:27Z","timestamp":1734006147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Different patterns of acute saccadic response to levodopa in de novo Parkinson\u2019s disease"],"prefix":"10.1007","volume":"272","author":[{"given":"Claudio","family":"Terravecchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Mostile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Grazia","family":"Chisari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Contrafatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Donzuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero Edoardo","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Sciacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-9486","authenticated-orcid":false,"given":"Mario","family":"Zappia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"12","key":"12802_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424. (PMID: 26474316)","journal-title":"Mov Disord"},{"issue":"11","key":"12802_CR2","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/mds.26712","volume":"31","author":"J Nonnekes","year":"2016","unstructured":"Nonnekes J, Timmer MH, de Vries NM, Rascol O, Helmich RC, Bloem BR (2016) Unmasking levodopa resistance in Parkinson\u2019s disease. Mov Disord 31(11):1602\u20131609. https:\/\/doi.org\/10.1002\/mds.26712. (Epub 2016 Jul 19 PMID: 27430479)","journal-title":"Mov Disord"},{"issue":"14","key":"12802_CR3","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/mds.25687","volume":"28","author":"DE Vaillancourt","year":"2013","unstructured":"Vaillancourt DE, Schonfeld D, Kwak Y, Bohnen NI, Seidler R (2013) Dopamine overdose hypothesis: evidence and clinical implications. Mov Disord 28(14):1920\u20131929. https:\/\/doi.org\/10.1002\/mds.25687. (Epub 2013 Oct 9. PMID: 24123087; PMCID: PMC3859825)","journal-title":"Mov Disord"},{"key":"12802_CR4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/mds.25364","volume":"28","author":"C Warren Olanow","year":"2013","unstructured":"Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH et al (2013) Reduction in dyskinesia evaluation in parkinson\u2019s disease (STRIDE-PD) investigators. Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson\u2019s disease. Mov Disord 28:1064\u20131071. https:\/\/doi.org\/10.1002\/mds.25364","journal-title":"Mov Disord"},{"issue":"1","key":"12802_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00019052-200402000-00005","volume":"17","author":"C Pierrot-Deseilligny","year":"2004","unstructured":"Pierrot-Deseilligny C, Milea D, M\u00fcri RM (2004) Eye movement control by the cerebral cortex. Curr Opin Neurol 17(1):17\u201325. https:\/\/doi.org\/10.1097\/00019052-200402000-00005. (PMID: 15090873)","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"12802_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrneurol.2012.273","volume":"9","author":"TJ Anderson","year":"2013","unstructured":"Anderson TJ, MacAskill MR (2013) Eye movements in patients with neurodegenerative disorders. Nat Rev Neurol 9(2):74\u201385. https:\/\/doi.org\/10.1038\/nrneurol.2012.273. (Epub 2013 Jan 22 PMID: 23338283)","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"12802_CR7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.clinph.2013.01.021","volume":"124","author":"Y Terao","year":"2013","unstructured":"Terao Y, Fukuda H, Ugawa Y, Hikosaka O (2013) New perspectives on the pathophysiology of Parkinson\u2019s disease as assessed by saccade performance: a clinical review. Clin Neurophysiol 124(8):1491\u20131506. https:\/\/doi.org\/10.1016\/j.clinph.2013.01.021. (Epub 2013 Mar 13 PMID: 23499161)","journal-title":"Clin Neurophysiol"},{"key":"12802_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.pbr.2019.05.001","volume":"249","author":"AG Shaikh","year":"2019","unstructured":"Shaikh AG, Ghasia FF (2019) Saccades in Parkinson\u2019s disease: hypometric, slow, and maladaptive. Prog Brain Res 249:81\u201394. https:\/\/doi.org\/10.1016\/bs.pbr.2019.05.001. (Epub 2019 Jun 20 PMID: 31325999)","journal-title":"Prog Brain Res"},{"issue":"5","key":"12802_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/brain\/112.5.1193","volume":"112","author":"O Rascol","year":"1989","unstructured":"Rascol O, Clanet M, Montastruc JL, Simonetta M, Soulier-Esteve MJ, Doyon B, Rascol A (1989) Abnormal ocular movements in Parkinson\u2019s disease. Evidence for involvement of dopaminergic systems. Brain 112(5):1193\u20131214. https:\/\/doi.org\/10.1093\/brain\/112.5.1193. (PMID: 2804611)","journal-title":"Brain"},{"key":"12802_CR10","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3109\/00016489109131470","volume":"481","author":"T Nakamura","year":"1991","unstructured":"Nakamura T, Kanayama R, Sano R, Ohki M, Kimura Y, Aoyagi M, Koike Y (1991) Quantitative analysis of ocular movements in Parkinson\u2019s disease. Acta Otolaryngol Suppl 481:559\u2013562. https:\/\/doi.org\/10.3109\/00016489109131470. (PMID: 1681674)","journal-title":"Acta Otolaryngol Suppl"},{"issue":"2","key":"12802_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF02260964","volume":"7","author":"C M\u00fcller","year":"1994","unstructured":"M\u00fcller C, Wenger S, Fertl L, Auff E (1994) Initiation of visual-guided random saccades and remembered saccades in parkinsonian patients with severe motor-fluctuations. J Neural Transm Park Dis Dement Sect 7(2):101\u2013108. https:\/\/doi.org\/10.1007\/BF02260964. (PMID: 7710662)","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"1","key":"12802_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00221-006-0412-z","volume":"174","author":"AW Michell","year":"2006","unstructured":"Michell AW, Xu Z, Fritz D, Lewis SJ, Foltynie T, Williams-Gray CH, Robbins TW, Carpenter RH, Barker RA (2006) Saccadic latency distributions in Parkinson\u2019s disease and the effects of L-dopa. Exp Brain Res 174(1):7\u201318. https:\/\/doi.org\/10.1007\/s00221-006-0412-z. (Epub 2006 Mar 17. PMID: 16544135; PMCID: PMC1877863)","journal-title":"Exp Brain Res"},{"issue":"6","key":"12802_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/jnnp.2006.099754","volume":"78","author":"AJ Hood","year":"2007","unstructured":"Hood AJ, Amador SC, Cain AE, Briand KA, Al-Refai AH, Schiess MC, Sereno AB (2007) Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 78(6):565\u2013570. https:\/\/doi.org\/10.1136\/jnnp.2006.099754. (Epub 2006 Dec 18. PMID: 17178817; PMCID: PMC2077956)","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"12802_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jocn.2011.10.014","volume":"19","author":"S van Stockum","year":"2012","unstructured":"van Stockum S, MacAskill MR, Anderson TJ (2012) Impairment of voluntary saccades and facilitation of reflexive saccades do not co-occur in Parkinson\u2019s disease. J Clin Neurosci 19(8):1119\u20131124. https:\/\/doi.org\/10.1016\/j.jocn.2011.10.014. (Epub 2012 Jun 15 PMID: 22705130)","journal-title":"J Clin Neurosci"},{"issue":"3","key":"12802_CR15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.clinph.2013.06.188","volume":"125","author":"S Cubizolle","year":"2014","unstructured":"Cubizolle S, Damon-Perri\u00e8re N, Dupouy S, Foubert-Samier A, Tison F (2014) Parkinson\u2019s disease, L-Dopa and \u201cexpress\u201d saccades: superior colliculus dyskinesias? Clin Neurophysiol 125(3):647\u2013648. https:\/\/doi.org\/10.1016\/j.clinph.2013.06.188. (Epub 2013 Aug 31 PMID: 24001969)","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"12802_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.pjnns.2017.06.002","volume":"51","author":"M Dec-\u0106wiek","year":"2017","unstructured":"Dec-\u0106wiek M, Tutaj M, Gracies JM, Volkmann J, Rudzi\u0144ska M, S\u0142owik A, Szczudlik A (2017) Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson\u2019s disease. Neurol Neurochir Pol 51(5):354\u2013360. https:\/\/doi.org\/10.1016\/j.pjnns.2017.06.002. (Epub 2017 Jun 24 PMID: 28669542)","journal-title":"Neurol Neurochir Pol"},{"issue":"5","key":"12802_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-019-0083-7.PMID:31263745;PMCID:PMC6591173","volume":"24","author":"J Waldthaler","year":"2019","unstructured":"Waldthaler J, Tsitsi P, Svenningsson P (2019) Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson\u2019s disease. NPJ Parkinsons Dis 24(5):11. https:\/\/doi.org\/10.1038\/s41531-019-0083-7.PMID:31263745;PMCID:PMC6591173","journal-title":"NPJ Parkinsons Dis"},{"key":"12802_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.parkreldis.2019.09.029","volume":"68","author":"Z Lu","year":"2019","unstructured":"Lu Z, Buchanan T, Kennard C, FitzGerald JJ, Antoniades CA (2019) The effect of levodopa on saccades - Oxford quantification in Parkinsonism study. Parkinsonism Relat Disord 68:49\u201356. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.09.029. (Epub 2019 Sep 27 PMID: 31621619)","journal-title":"Parkinsonism Relat Disord"},{"key":"12802_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clinph.2022.07.505","volume":"143","author":"MJ Munoz","year":"2022","unstructured":"Munoz MJ, Reilly JL, Pal GD, Verhagen Metman L, Rivera YM, Drane QH, Corcos DM, David FJ, Goelz LC (2022) Medication adversely impacts visually-guided eye movements in Parkinson\u2019s disease. Clin Neurophysiol 143:145\u2013153. https:\/\/doi.org\/10.1016\/j.clinph.2022.07.505. (Epub 2022 Aug 8 PMID: 35995722)","journal-title":"Clin Neurophysiol"},{"issue":"5","key":"12802_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC (2013) How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale. Mov Disord 28(5):668\u2013670. https:\/\/doi.org\/10.1002\/mds.25383. (Epub 2013 Feb 13 PMID: 23408503)","journal-title":"Mov Disord"},{"issue":"1","key":"12802_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/mds.870120118","volume":"12","author":"M Zappia","year":"1997","unstructured":"Zappia M, Montesanti R, Colao R, Branca D, Nicoletti G, Aguglia U, Quattrone A (1997) Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson\u2019s disease. Mov Disord 12(1):103\u2013106. https:\/\/doi.org\/10.1002\/mds.870120118. (PMID: 8990062)","journal-title":"Mov Disord"},{"issue":"1","key":"12802_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3758\/s13428-020-01388-2","volume":"53","author":"A Gibaldi","year":"2021","unstructured":"Gibaldi A, Sabatini SP (2021) The saccade main sequence revised: A fast and repeatable tool for oculomotor analysis. Behav Res Methods 53(1):167\u2013187. https:\/\/doi.org\/10.3758\/s13428-020-01388-2. (PMID:32643061;PMCID:PMC7880984)","journal-title":"Behav Res Methods"},{"issue":"6","key":"12802_CR23","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s10072-020-04796-6","volume":"42","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhang B, Ren Q, Zhong Q, Li Y, Liu G, Ma X, Zhao C (2021) Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson\u2019s disease. Neurol Sci 42(6):2337\u20132345. https:\/\/doi.org\/10.1007\/s10072-020-04796-6. (Epub 2020 Oct 12 PMID: 33043395)","journal-title":"Neurol Sci"},{"issue":"2","key":"12802_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"Suppl 2","key":"12802_CR25","doi-asserted-by":"publisher","first-page":"S284","DOI":"10.1007\/s00415-010-5731-0","volume":"257","author":"M Zappia","year":"2010","unstructured":"Zappia M, Nicoletti A (2010) The role of the long-duration response to levodopa in Parkinson\u2019s disease. J Neurol 257(Suppl 2):S284\u2013S287. https:\/\/doi.org\/10.1007\/s00415-010-5731-0. (PMID: 21080190)","journal-title":"J Neurol"},{"issue":"14","key":"12802_CR26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease. Pathophysiologic and clinical implications. N Engl J Med 318(14):876\u2013880. https:\/\/doi.org\/10.1056\/NEJM198804073181402. (PMID: 3352672)","journal-title":"N Engl J Med"},{"issue":"4","key":"12802_CR27","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.neuroimage.2003.12.014","volume":"21","author":"M Carbon","year":"2004","unstructured":"Carbon M, Ma Y, Barnes A, Dhawan V, Chaly T, Ghilardi MF, Eidelberg D (2004) Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. Neuroimage 21(4):1497\u20131507. https:\/\/doi.org\/10.1016\/j.neuroimage.2003.12.014. (PMID: 15050574)","journal-title":"Neuroimage"},{"key":"12802_CR28","doi-asserted-by":"publisher","first-page":"108082","DOI":"10.1016\/j.neuropsychologia.2021.108082","volume":"163","author":"J Waldthaler","year":"2021","unstructured":"Waldthaler J, Stock L, Kr\u00fcger-Zechlin C, Timmermann L (2021) Age at Parkinson\u2019s disease onset modulates the effect of levodopa on response inhibition: Support for the dopamine overdose hypothesis from the antisaccade task. Neuropsychologia 163:108082. https:\/\/doi.org\/10.1016\/j.neuropsychologia.2021.108082. (Epub 2021 Oct 30 PMID: 34728241)","journal-title":"Neuropsychologia"},{"issue":"2","key":"12802_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00002826-200203000-00004","volume":"25","author":"M Zappia","year":"2002","unstructured":"Zappia M, Crescibene L, Arabia G, Nicoletti G, Bagal\u00e0 A, Bastone L, Caracciolo M, Bonavita S, Di Costanzo A, Scornaienchi M, Gambardella A, Quattrone A (2002) Body weight influences pharmacokinetics of levodopa in Parkinson\u2019s disease. Clin Neuropharmacol 25(2):79\u201382. https:\/\/doi.org\/10.1097\/00002826-200203000-00004. (PMID: 11981233)","journal-title":"Clin Neuropharmacol"},{"issue":"9","key":"12802_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.909936","volume":"31","author":"V Conti","year":"2022","unstructured":"Conti V, Izzo V, Russillo MC, Picillo M, Amboni M, Scaglione CLM, Nicoletti A, Cani I, Cicero CE, De Bellis E, Charlier B, Giudice V, Somma G, Corbi G, Barone P, Filippelli A, Pellecchia MT (2022) Gender differences in levodopa pharmacokinetics in levodopa-na\u00efve patients with Parkinson\u2019s disease. Front Med (Lausanne) 31(9):909936. https:\/\/doi.org\/10.3389\/fmed.2022.909936. (PMID:35712091;PMCID:PMC9193)","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12802-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12802-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12802-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:55:56Z","timestamp":1738173356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12802-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12802"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12802-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by the local ethics committee (Comitato Etico Catania 1, Protocol Number: 2024\/2017). Written informed consents were obtained from study subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"24"}}